BerGenBio ASA (BGBIO.OL)

NOK 1.76

(3.9%)

Total Debt Summary of BerGenBio ASA

BerGenBio ASA's latest annual total debt in 2023 was 418 Thousand NOK , up 52.0% from previous year.
BerGenBio ASA's latest quarterly total debt in 2024 Q2 was - NOK , down 0.0% from previous quarter.
BerGenBio ASA reported annual total debt of 275 Thousand NOK in 2022, down -83.06% from previous year.
BerGenBio ASA reported annual total debt of 1.62 Million NOK in 2021, down -19.53% from previous year.
BerGenBio ASA reported quarterly total debt of - NOK for 2024 Q2, down 0.0% from previous quarter.
BerGenBio ASA reported quarterly total debt of 418 Thousand NOK for 2023 FY, up 52.0% from previous quarter.

Annual Total Debt Chart of BerGenBio ASA (2023 - 2014)

Historical Annual Total Debt of BerGenBio ASA (2023 - 2014)

Year	Total Debt	Total Debt Growth
2023	418 Thousand NOK	52.0%
2022	275 Thousand NOK	-83.06%
2021	1.62 Million NOK	-19.53%
2020	2.01 Million NOK	244.79%
2019	585 Thousand NOK	0.0%
2018	- NOK	-100.0%
2017	20.34 Million NOK	12.84%
2016	18.02 Million NOK	1510.9%
2015	1.11 Million NOK	0.0%
2014	- NOK	0.0%

Year	Total Debt	Total Debt Growth
2024 Q1	- NOK	-100.0%
2024 Q2	- NOK	0.0%
2023 FY	418 Thousand NOK	52.0%
2023 Q3	101 Thousand NOK	0.0%
2023 Q1	650 Thousand NOK	136.36%
2023 Q4	418 Thousand NOK	313.86%
2023 Q2	- NOK	-100.0%
2022 Q4	275 Thousand NOK	0.0%
2022 FY	275 Thousand NOK	-83.06%
2022 Q1	796 Thousand NOK	-50.96%
2022 Q2	651 Thousand NOK	-18.22%
2022 Q3	- NOK	-100.0%
2021 FY	1.62 Million NOK	-19.53%
2021 Q4	1.62 Million NOK	59.74%
2021 Q3	1.01 Million NOK	-18.06%
2021 Q2	1.24 Million NOK	-5.27%
2021 Q1	1.3 Million NOK	-35.1%
2020 Q2	- NOK	0.0%
2020 Q1	- NOK	-100.0%
2020 FY	2.01 Million NOK	244.79%
2020 Q4	2.01 Million NOK	0.0%
2020 Q3	- NOK	0.0%
2019 Q2	248 Thousand NOK	-19.22%
2019 Q1	307 Thousand NOK	0.0%
2019 FY	585 Thousand NOK	0.0%
2019 Q3	63 Thousand NOK	-74.6%
2019 Q4	585 Thousand NOK	828.57%
2018 Q3	- NOK	0.0%
2018 Q1	- NOK	0.0%
2018 FY	- NOK	-100.0%
2018 Q4	- NOK	0.0%
2018 Q2	- NOK	0.0%
2017 Q4	- NOK	0.0%
2017 Q3	- NOK	0.0%
2017 Q2	- NOK	0.0%
2017 FY	20.34 Million NOK	12.84%
2016 Q4	- NOK	0.0%
2016 FY	18.02 Million NOK	1510.9%
2015 FY	1.11 Million NOK	0.0%
2014 FY	- NOK	0.0%

Peer Total Debt Comparison of BerGenBio ASA

Name	Total Debt	Total Debt Difference
Arctic Bioscience AS	2.04 Million NOK	79.597%
Aqua Bio Technology ASA	7.12 Million NOK	94.132%
ArcticZymes Technologies ASA	12.58 Million NOK	96.68%
Hofseth BioCare ASA	136.78 Million NOK	99.694%
PCI Biotech Holding ASA	319 Thousand NOK	-31.034%
Thor Medical ASA	- NOK	-Infinity%
Ultimovacs ASA	3.71 Million NOK	88.742%